Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Inhaled Cannabis Versus Placebo for the Acute Treatment of Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Trial

NCT04360044 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT04360044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04360044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Inhaled Cannabis Versus Placebo for the Acute Treatment of Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Trial
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Completed
Start date
November 20, 2020
Completion date
February 23, 2023
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis, cbd, migraine, thc